Unlocking Protein Biomarker Discovery for Pharma, Biotech and Academia

Xtalks presents a live webinar on August 23, 2012 at 11:00am EDT on protein biomarker discovery. Dr. Steve Williams, Chief Medical Officer, SomaLogic, and Dr. Nick Saccomano, Chief Technology Officer, SomaLogic, will discuss a transformative proteomic biomarker discovery technology developed by SomaLogic that measures over 1129 human proteins in small sample volumes (50 µL) with a sensitive, specific and semi-automated assay. Register for the webinar at http://xtks.in/xto501.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Toronto, Canada (PRWEB) August 11, 2012

To date SomaLogic has assayed more than 20,000 samples, mostly clinical in nature, including a wide range of therapeutic areas. Matrices that have been run on their assay include serum, plasma, cells (both lysates and media), tissues, CSF, synovial fluid, and BAL.

SomaLogic is now offering academia, pharma and biotech companies access to this platform. This webinar will provide a brief overview of the technology and some example applications derived from it. We welcome you to join us to learn about this revolution in proteomics.

For more information or to register go to http://xtks.in/xto501.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com


Contact

  • Client Services
    Xtalks
    (416) 977-6555 227
    Email